# FDA Inspection 1223673 - Regenerative Biologics Inc - November 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/ca17f6fb-83b9-482c-9b0e-24deb1e2a88f
Source feed: FDA_Inspections

> FDA Inspection 1223673 for Regenerative Biologics Inc on November 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223673
- Company Name: Regenerative Biologics Inc
- Inspection Date: 2023-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223673 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/ed3bcd5c-c546-44ab-925b-58b83efbc19a)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/185d2055-ffdb-4eb2-ae26-d904f7d88b0d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d